# Beta Blocker Therapy in Mild to Moderate Asthmatics

> **NCT01544634** · PHASE2 · COMPLETED · sponsor: **University of Dundee** · enrollment: 16 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Placebo
- **DRUG:** Qvar 50
- **DRUG:** Qvar 100

## Key facts

- **NCT ID:** NCT01544634
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-04
- **Primary completion:** 2013-05-25
- **Final completion:** 2013-05-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01544634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01544634, "Beta Blocker Therapy in Mild to Moderate Asthmatics". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01544634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*